Seers Technology
Seers Technology (rebranding as SEERS) is a KOSDAQ-listed South Korean digital healthcare company that sells AI-powered wearable biosensors and inpatient monitoring platforms (mobiCARE ECG analysis and thynC hospital monitoring) to hospitals and outpatient cardiology providers, primarily in Korea with expanding presence in the UAE.
- Company typePublic
- Founded2009
- HeadquartersSeongnam, South Korea
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Seers Technology does
Seers Technology (rebranding to SEERS) is a South Korea-based digital healthcare company, founded in 2009 and listed on KOSDAQ under ticker 458870, that develops and commercializes wearable biosensors and AI-powered patient monitoring platforms for hospitals and outpatient cardiology use. Its product portfolio is anchored by two platforms: mobiCARE™, a subscription-based wearable ECG analysis service using a patch-type biosensor capable of up to 9 days of continuous monitoring and an AI algorithm that detects 14+ types of arrhythmias from deep-learning analysis of ECG waveforms validated on data from over 80,000 patients; and thynC™, a real-time inpatient monitoring system integrating patch-type ECG, temperature, and pulse oximetry sensors with a gateway, central nursing dashboard, mobile monitoring app, and an AI-driven Early Warning Score that fuses heart rate, blood pressure, respiration, and temperature to flag patient deterioration. Seers also sells standalone wearable biosensors (Holter ECG, IR temperature patch, pulse oximeter) and medical adhesive materials through an OEM/ODM line, all manufactured under GMP with ISO 13485, MDSAP, MFDS, FDA 510(k), and CE certifications.
The company generates revenue through a mix of subscription-based software/services (mobiCARE ECG analysis, thynC monitoring subscriptions), hardware sales of biosensor devices, and licensing/integration of third-party devices such as Sky Labs' CART ON ring into thynC. Domestic distribution runs primarily through enterprise direct sales plus an exclusive channel partnership with Daewoong Pharmaceutical, which targets scaling thynC from 15,000 to 100,000 Korean hospital beds; international expansion is led through a strategic partnership with PureHealth in the UAE as the first overseas foothold, with Middle East and United States entry planned. In FY2025 Seers reported 48.17 billion KRW (~$36M USD) in revenue, up 495% year-on-year, with its first full-year operating profit of 16.33 billion KRW, making it Korea's first publicly listed medical AI company to achieve annual profitability. The thynC platform is currently installed across 12,000+ beds at 128 domestic hospitals (and adopted by a broader set of 400–700+ hospitals across product lines), with new functions added via partnerships with SkyLab, iKooB, and Puzzle AI.
Seers Technology firmographics
Firmographics- Name
- Seers Technology
- Legal name
- SEERS Technology Co., Ltd.
- Website
- https://seers.co.kr
- Company type
- Public
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Seers Technology (rebranding as SEERS) is a KOSDAQ-listed South Korean digital healthcare company that sells AI-powered wearable biosensors and inpatient monitoring platforms (mobiCARE ECG analysis and thynC hospital monitoring) to hospitals and outpatient cardiology providers, primarily in Korea with expanding presence in the UAE.
- Ownership category
- akta.pro rank
Seers Technology industry classification
Industry- Product category
- Remote Patient Monitoring
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB), Wearables & Consumer IoT Integration Platforms (BYOD) (HLACAFAF)
Keywords
Where Seers Technology is headquartered
LocationHeadquarters
- HQ city
- Seongnam
- HQ country
- South Korea
- HQ region
- Asia
Offices3 records
Markets served
Seers Technology business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- thynC Platform Revenue: Revenue from the thynC inpatient monitoring platform including wearable biosensors, gateway devices, dashboards, and monitoring software. Installed in over 12,000 beds across 128 domestic hospitals.
- mobiCARE ECG Analysis Service: First subscription-based ECG analysis service in Korea. Provides wearable ECG monitoring with AI analysis and specialist-reviewed reports for outpatients and health checkups.
- Wearable Biosensor Hardware: Sales of wearable medical devices including ECG holters, thermometers, pulse oximeters, and related sensors.
- Technology Integration (thynC): Integration of third-party devices like Sky Labs' CART ON blood pressure ring into the thynC platform for hospital inpatient monitoring.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | mobiCARE Premium - Full ECG analysis with specialist review |
| Subscription | Monthly | mobiCARE Standard - AI analysis only |
| Subscription | Pay-as-you-go | Health Checkup ECG Service - Variable duration options |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Seers Technology product offering
Product offeringCore offering
Seers Technology develops and sells AI-powered wearable biosensors and patient monitoring platforms. Its two flagship solutions are thynC, a real-time inpatient monitoring platform that integrates wearable sensors, gateways, central and mobile dashboards for continuous vital sign collection and AI-driven early warning alerts in hospitals, and mobiCARE, Korea's first subscription-based ECG analysis service using a patch-type wearable holter with AI arrhythmia detection for outpatients and health checkup centers.
Product overview
Seers Technology (rebranding as SEERS) is a digital healthcare company offering an integrated platform of remote patient monitoring solutions. Its product portfolio consists of two core platforms: mobiCARE™ (a subscription-based wearable ECG analysis solution for outpatients) and thynC™ (a real-time inpatient monitoring solution), both supported by a range of wearable biosensor devices (Electrocardiographic Holter analyser, Thermometer, Pulse Oximeter), patient monitoring software (Monitoring Dashboard, Hospital Ward Managing Software, Mobile Monitoring Software), and Medical AI features (ECG Analysis Algorithm, Temperature Monitoring AI, Early Warning Score, Location Tracking, Fall Detection, Activity Measurement). The company also offers Medical Adhesive Materials for its wearable sensors. All products are produced within GMP-certified manufacturing infrastructure and leverage proprietary AI algorithms validated through clinical studies.
Differentiator
Problem solved
Functional benefit
Brands
- mobiCARE™: First subscription-based ECG analysis service in Korea. Provides wearable Holter electrocardiogram for arrhythmia detection with up to 9-day continuous monitoring and AI-based analysis algorithms detecting 14+ types of arrhythmias.
- thynC™
Products and services
- mobiCARE™ Korea's first subscription-based ECG analysis solution combining a patch-type wearable biosensor (up to 9-day continuous monitoring), a deep learning-powered analysis program, and arrhythmia specialist-reviewed reports to detect 14+ types of arrhythmias for outpatients and health checkup centers.
- thynC™ Real-time inpatient monitoring solution that integrates wearable biosensors, an IoT gateway, a central dashboard, and a mobile dashboard to continuously measure, collect, transmit, store, and analyze patient biometric signals, with AI-powered Early Warning Score alerts to reduce gaps in patient management in hospitals.
- Wearable Holter ECG (Electrocardiographic Holter analyser) A patch-type wearable ECG device optimized for arrhythmia detection, capable of continuous monitoring for up to 9 days without battery replacement, designed for patients, doctors, and analysis experts to increase diagnostic accuracy.
- Wearable Patch Thermometer A patch-type thermometer using an infrared sensor for continuous body temperature monitoring, made with skin-friendly silicone material to reduce infection risk and skin irritation.
- Wearable Pulse Oximeter A wearable pulse oximeter using a reusable sensor and disposable universal probe that measures oxygen saturation, heart rate, respiration rate, and perfusion index without blood collection, with medical device certification and clinically proven stability and efficacy.
- Medical Adhesive Materials Medical-grade adhesive solutions including silicone gel, hydrocolloid, conductive hydrogel, and adhesive hydrogel for long-term skin-friendly wear of patch-type wearable biosensors, along with medical patch products and OEM/ODM manufacturing services.
Quantifiable outcome
- 12,000+ cumulative installed beds across 128 hospitals
- +4 more outcomes
Companies that use Seers Technology
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Seers Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Seers Technology partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and strategic.
- Daewoong PharmaceuticalcoreDaewoong Pharmaceutical serves as Korea's exclusive distributor for Seers Technology's thynC patient monitoring platform. Daewoong plans to expand the thynC system to 100,000 hospital beds by end of 2026 (up from 15,000 beds at 162 hospitals). Daewoong also added three new functions from SkyLab, iKooB, and Puzzle AI to the platform. Daewoong has exclusive domestic sales rights and plans nationwide hospital distribution.
- Sky LabscoreSky Labs' CART ON ring-type blood pressure monitor integrates with Seers' thynC inpatient monitoring platform. Data from the wearable ring device is automatically transmitted to nursing station dashboards and hospital EMR systems via thynC. This expands thynC's monitoring capabilities to include cuffless blood pressure monitoring for hospital inpatients.
- PureHealthstrategicPartnership with PureHealth for UAE market expansion as a strategic foothold for international growth. This represents Seers' first major overseas market entry.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
Seers Technology competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: GE HealthCare provides multi-parameter patient monitoring systems and AI-enabled clinical tools across hospital environments, competing with Seers' thynC inpatient monitoring platform in larger Korean tertiary hospitals.
- Hillrom (Baxter): Hillrom (acquired by Baxter) supplies hospital patient monitoring and connected care solutions including wearable sensors and nurse communication systems, competing in the inpatient monitoring category Seers targets with thynC.
- Philips (Patient Monitoring): Philips offers broad inpatient and ambulatory patient monitoring solutions including wearable biosensors, central stations, and AI analytics, overlapping directly with Seers' thynC platform across Korean and Asian hospital markets.
Emerging players
- Biobeat: Biobeat offers wearable continuous vital sign monitoring patches with AI analytics for inpatient and remote patient monitoring, comparable to Seers' thynC platform in the connected RPM space.
- VivaLNK: VivaLNK provides connected wearable biosensor patches and RPM platforms used by hospitals and clinical trials, comparable to Seers' thynC integration with multi-vendor wearable devices.
Regional players
- VUNO: VUNO is a Korean medical AI company listed on KOSDAQ that develops AI-based clinical decision support tools, a regional peer in the Korean medical AI ecosystem targeting similar hospital customers.
Direct peers
- iRhythm Technologies: iRhythm's Zio patch is a direct competitor to Seers' mobiCARE wearable Holter ECG, offering multi-day continuous ECG monitoring with AI-based arrhythmia detection for outpatient and ambulatory use.
- AliveCor: AliveCor's KardiaMobile personal ECG devices and AI-based arrhythmia detection service offer a consumer-grade subscription alternative to Seers' mobiCARE outpatient ECG analysis service.
- Masimo: Masimo's wearable patient monitoring sensors (like Radius PPG and SET pulse oximetry) and connected care platform compete with Seers' pulse oximetry, temperature, and remote vital signs monitoring offerings.
- Preventice Solutions (Boston Scientific): Preventice's BodyGuardian remote cardiac monitoring system uses wearable ECG patches with AI arrhythmia detection for ambulatory monitoring, directly comparable to Seers' mobiCARE subscription service.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Seers Technology social profiles
Digital presenceSeers Technology compliance and trust
Trust signalCompliance9 records
Seers Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Seers Technology leadership team
Management profileNumber of profiles
Profiles6 records
Seers Technology funding detail
Funding detailFunding overview
Funding rounds1 record
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Seers Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Seers Technology
What does Seers Technology do?
Seers Technology develops and sells AI-powered wearable biosensors and patient monitoring platforms. Its two flagship solutions are thynC, a real-time inpatient monitoring platform that integrates wearable sensors, gateways, central and mobile dashboards for continuous vital sign collection and AI-driven early warning alerts in hospitals, and mobiCARE, Korea's first subscription-based ECG analysis service using a patch-type wearable holter with AI arrhythmia detection for outpatients and health checkup centers.
Is Seers Technology a public or private company?
Seers Technology is a public company. It is classified as public and is currently operating.
When was Seers Technology founded?
Seers Technology was founded in 2009. It employs 51 to 100 people.
Where is Seers Technology based?
Seers Technology is headquartered in Seongnam, South Korea, in the Asia region.
How does Seers Technology make money?
Four revenue lines are on record. thynC Platform Revenue is the primary driver. The others are mobiCARE ECG Analysis Service, wearable Biosensor Hardware and technology Integration (thynC).
Who are Seers Technology's main competitors?
Broad incumbents on record are GE HealthCare, Hillrom (Baxter) and Philips (Patient Monitoring). Emerging players are Biobeat and VivaLNK. VUNO is listed as a regional player. Direct peers are iRhythm Technologies, AliveCor, Masimo and Preventice Solutions (Boston Scientific).
Does Seers Technology have an API?
No public API is recorded for Seers Technology.
What industry is Seers Technology in?
Seers Technology's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3841.